Grants and Funding
NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: UCLA 7; disease-specific mutation/abnormal karyotype
NIH Registration Number: 0143
NIH Approval Number: NIHhESC-12-0143
Available for Distribution: Other - possibly in future: contact speckman@mednet.ucla.edu
Provider Restrictions: hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.

NIH Restrictions: (No Additional Restrictions)
Additional Information: UCLA 7 (47, XX+13) was karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.

Submitting Organization: University of California, Los Angeles
Provider Name: Steven Peckman
Provider Phone: 310-794-4919
Provider Email: speckman@mednet.ucla.edu
Provider URL: www.stemcell.ucla.edu
Approval Date: 01/12/2012


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster